B-Diagnostic_tool	0	7	Optical
I-Diagnostic_tool	8	17	coherence
I-Diagnostic_tool	18	29	tomographic
O	30	37	pattern
O	38	41	may
O	42	49	predict
O	50	56	visual
O	57	64	outcome
O	65	70	after
O	71	83	intravitreal
O	84	97	triamcinolone
O	98	101	for
B-Disease	102	110	diabetic
I-Disease	111	118	macular
I-Disease	119	124	edema
O	124	125	.

O	127	129	To
O	130	138	identify
O	139	141	an
B-Diagnostic_tool	142	149	optical
I-Diagnostic_tool	150	159	coherence
I-Diagnostic_tool	160	170	tomography
O	171	172	(
B-Diagnostic_tool	172	175	OCT
O	175	176	)
O	177	184	pattern
O	185	195	predictive
O	196	198	of
O	199	205	visual
O	206	213	outcome
O	214	216	in
O	217	225	patients
O	226	230	with
B-Disease	231	239	diabetic
I-Disease	240	247	macular
I-Disease	248	253	edema
O	254	255	(
B-Disease	255	258	DME
O	258	259	)
O	260	263	who
O	264	273	underwent
O	274	275	a
O	276	282	single
O	283	287	dose
O	288	290	of
O	291	303	intravitreal
O	304	317	triamcinolone
O	317	318	.

O	319	332	Retrospective
O	333	337	case
O	338	346	analysis
O	347	351	with
O	352	363	prospective
O	364	368	data
O	369	379	collection
O	380	383	for
O	384	392	controls
O	392	393	.

O	394	400	Ninety
O	400	401	-
O	401	406	three
O	407	412	cases
O	413	416	and
O	417	419	25
O	420	428	controls
O	428	429	.

O	430	433	Two
O	434	445	independent
O	446	452	masked
O	453	462	observers
O	463	478	retrospectively
O	479	487	examined
O	488	500	preoperative
B-Anatomy	501	508	macular
B-Diagnostic_tool	509	513	OCTs
O	514	516	of
O	517	519	93
B-Anatomy	520	524	eyes
O	525	527	of
O	528	530	93
O	531	539	patients
O	540	543	who
O	544	548	were
O	549	554	given
O	555	556	a
O	557	563	single
O	564	568	dose
O	569	570	(
O	570	571	4
O	572	574	mg
O	575	577	in
O	578	579	0
O	579	580	.
O	580	581	1
O	582	584	ml
O	584	585	)
O	586	588	of
O	589	601	intravitreal
O	602	615	triamcinolone
O	616	619	for
B-Disease	620	623	DME
O	624	627	and
O	628	639	categorized
O	640	644	them
O	645	647	as
O	648	657	belonging
O	658	660	to
O	661	662	2
O	663	669	groups
O	669	670	:
O	671	672	1
O	672	673	,
O	674	683	comprised
O	684	686	of
B-Anatomy	687	691	eyes
O	692	696	with
B-Characteristic	697	701	high
I-Characteristic	702	714	reflectivity
O	715	716	(
O	716	722	bright
O	723	729	colors
O	729	730	)
O	731	735	from
B-Anatomy	736	741	inner
I-Anatomy	742	749	retinal
I-Anatomy	750	756	layers
O	756	757	,
O	758	761	and
O	762	763	2
O	763	764	,
O	765	774	comprised
O	775	777	of
B-Anatomy	778	782	eyes
O	783	787	that
O	788	791	had
B-Characteristic	792	795	low
I-Characteristic	796	808	reflectivity
O	809	810	(
O	810	816	darker
O	817	823	colors
O	823	824	)
O	825	829	from
B-Anatomy	830	835	inner
I-Anatomy	836	843	retinal
I-Anatomy	844	850	layers
O	850	851	.

O	852	861	Logarithm
O	862	864	of
O	865	868	the
B-Characteristic	869	876	minimum
I-Characteristic	877	882	angle
I-Characteristic	883	885	of
I-Characteristic	886	896	resolution
I-Characteristic	897	903	visual
I-Characteristic	904	910	acuity
O	911	912	(
B-Characteristic	912	914	VA
O	914	915	)
O	916	919	and
B-Characteristic	920	927	macular
I-Characteristic	928	937	thickness
O	938	946	measured
O	947	949	by
B-Diagnostic_tool	950	953	OCT
O	954	958	were
O	959	967	assessed
O	968	982	preoperatively
O	983	986	and
O	987	1002	postoperatively
O	1003	1005	at
O	1006	1007	1
O	1008	1011	and
O	1012	1013	3
O	1014	1020	months
O	1020	1021	.

B-Diagnostic_tool	1022	1029	Optical
I-Diagnostic_tool	1030	1039	coherence
I-Diagnostic_tool	1040	1051	tomographic
O	1052	1062	appearance
O	1063	1065	of
B-Anatomy	1066	1071	inner
I-Anatomy	1072	1079	retinal
I-Anatomy	1080	1086	layers
O	1086	1087	.

O	1088	1091	All
O	1092	1100	patients
O	1101	1110	completed
O	1111	1112	3
O	1113	1119	months
O	1120	1122	of
O	1123	1129	follow
O	1129	1130	-
O	1130	1132	up
O	1132	1133	.

O	1134	1136	In
O	1137	1142	group
O	1143	1144	1
O	1144	1145	,
O	1146	1148	45
O	1149	1151	of
O	1152	1154	51
B-Anatomy	1155	1159	eyes
O	1160	1161	(
O	1161	1163	88
O	1163	1164	%
O	1164	1165	)
O	1166	1177	experienced
O	1178	1184	visual
O	1185	1196	improvement
O	1197	1199	of
O	1201	1202	>
O	1204	1206	or
O	1207	1208	=
O	1208	1209	2
O	1210	1215	lines
O	1216	1218	on
O	1219	1221	an
B-Classification_system	1222	1227	Early
I-Classification_system	1228	1237	Treatment
I-Classification_system	1238	1246	Diabetic
I-Classification_system	1247	1258	Retinopathy
I-Classification_system	1259	1264	Study
O	1265	1266	(
B-Classification_system	1266	1271	ETDRS
O	1271	1272	)
O	1273	1278	chart
O	1279	1281	at
O	1282	1283	1
O	1284	1289	month
O	1290	1292	of
O	1293	1299	follow
O	1299	1300	-
O	1300	1302	up
O	1302	1303	.

O	1304	1309	Forty
O	1309	1310	-
O	1310	1314	four
O	1315	1317	of
O	1318	1320	51
O	1321	1329	patients
O	1330	1331	(
O	1331	1333	86
O	1333	1334	%
O	1334	1335	)
O	1336	1347	experienced
O	1348	1354	visual
O	1355	1366	improvement
O	1367	1369	of
O	1371	1372	>
O	1374	1376	or
O	1377	1378	=
O	1378	1379	2
O	1380	1385	lines
O	1386	1388	on
O	1389	1391	an
B-Classification_system	1392	1397	ETDRS
O	1398	1403	chart
O	1404	1406	at
O	1407	1408	3
O	1409	1415	months
O	1416	1418	of
O	1419	1425	follow
O	1425	1426	-
O	1426	1428	up
O	1428	1429	.

O	1430	1432	In
O	1433	1438	group
O	1439	1440	2
O	1440	1441	,
O	1442	1444	18
O	1445	1447	of
O	1448	1450	42
O	1451	1459	patients
O	1460	1461	(
O	1461	1463	43
O	1463	1464	%
O	1464	1465	)
O	1466	1477	experienced
O	1478	1484	visual
O	1485	1496	improvement
O	1497	1499	of
O	1501	1502	>
O	1504	1506	or
O	1507	1508	=
O	1508	1509	1
O	1510	1515	lines
O	1516	1518	on
O	1519	1521	an
B-Classification_system	1522	1527	ETDRS
O	1528	1533	chart
O	1534	1536	at
O	1537	1538	1
O	1539	1542	and
O	1543	1544	3
O	1545	1551	months
O	1552	1554	of
O	1555	1561	follow
O	1561	1562	-
O	1562	1564	up
O	1564	1565	.

O	1566	1569	For
O	1570	1573	the
O	1574	1583	remaining
O	1584	1592	patients
O	1592	1593	,
B-Characteristic	1594	1596	VA
O	1597	1605	remained
O	1606	1615	unchanged
O	1616	1622	during
O	1623	1626	the
O	1627	1640	postoperative
O	1641	1647	course
O	1648	1650	of
O	1651	1652	3
O	1653	1659	months
O	1659	1660	.

O	1661	1669	Patients
O	1670	1672	in
O	1673	1677	whom
B-Diagnostic_tool	1678	1681	OCT
O	1682	1694	demonstrated
O	1695	1698	the
B-Characteristic	1699	1703	high
I-Characteristic	1704	1716	reflectivity
O	1717	1719	of
B-Anatomy	1720	1725	inner
I-Anatomy	1726	1733	retinal
I-Anatomy	1734	1740	layers
O	1741	1749	achieved
O	1750	1757	greater
B-Characteristic	1758	1760	VA
O	1761	1767	though
B-Characteristic	1768	1775	macular
I-Characteristic	1776	1785	thickness
O	1786	1795	decreased
O	1796	1809	significantly
O	1810	1815	after
O	1816	1828	intravitreal
O	1829	1842	triamcinolone
O	1843	1845	in
O	1846	1850	both
O	1851	1857	groups
O	1857	1858	.

O	1859	1861	It
O	1862	1865	may
O	1866	1868	be
O	1869	1881	hypothesized
O	1882	1886	that
O	1887	1888	a
O	1889	1894	lower
B-Characteristic	1895	1902	optical
I-Characteristic	1903	1915	reflectivity
I-Characteristic	1916	1918	of
I-Characteristic	1919	1924	inner
I-Characteristic	1925	1932	retinal
I-Characteristic	1933	1939	layers
O	1940	1942	is
O	1943	1950	related
O	1951	1953	to
O	1954	1957	the
B-Symptom	1958	1965	atrophy
I-Symptom	1966	1968	of
I-Symptom	1969	1972	the
I-Symptom	1973	1978	inner
I-Symptom	1979	1986	retinal
I-Symptom	1987	1993	layers
O	1993	1994	,
O	1995	1999	thus
O	2000	2009	resulting
O	2010	2012	in
O	2013	2014	a
O	2015	2022	failure
O	2023	2025	of
B-Characteristic	2026	2028	VA
O	2029	2037	recovery
O	2038	2040	in
O	2041	2046	these
O	2047	2055	patients
O	2055	2056	.

O	2057	2060	The
O	2061	2066	level
O	2067	2069	of
O	2070	2082	reflectivity
O	2083	2087	from
B-Anatomy	2088	2093	inner
I-Anatomy	2094	2101	retinal
I-Anatomy	2102	2108	layers
O	2109	2111	on
B-Diagnostic_tool	2112	2115	OCT
O	2116	2119	may
O	2120	2127	provide
O	2128	2137	objective
O	2138	2146	criteria
O	2147	2149	in
O	2150	2160	predicting
O	2161	2164	the
O	2165	2173	response
O	2174	2176	of
B-Disease	2177	2180	DME
O	2181	2183	to
O	2184	2196	intravitreal
O	2197	2210	triamcinolone
O	2211	2214	and
O	2215	2219	help
O	2220	2222	in
O	2223	2235	preoperative
O	2236	2246	counseling
O	2247	2249	of
O	2250	2258	patients
O	2259	2263	with
B-Disease	2264	2267	DME
O	2267	2268	.
